The extent of cutaneous lesions predicts outcome in extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract with secondary cutaneous involvement

References

• Li YX, Yao B, Jin J, . Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol 2006;24:181–189.
   PubMed Web of Science ®Google Scholar
• Au WY, Weisenburger DD, Intragumtornchai T, . Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009;113:3931–3937.
   PubMed Web of Science ®Google Scholar
• Kim TM, Lee SY, Jeon YK, . Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group. Ann Oncol 2008;19:1477–1484.
   PubMed Web of Science ®Google Scholar
• Bossard C, Belhadj K, Reyes F, . Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood 2007;109:2183–2189.
   PubMed Web of Science ®Google Scholar
• Chim CS, Ma SY, Au WY, . Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 2004;103:216–221.
   PubMed Web of Science ®Google Scholar
• Li CC, Tien HF, Tang JL, . Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 2004;100:366–375.
   PubMed Web of Science ®Google Scholar
• Huang MJ, Jiang Y, Liu WP, . Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 2008;70:166–174.
   PubMed Web of Science ®Google Scholar
• Li YX, Fang H, Liu QF, . Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring. Blood 2008;112:3057–3064.
   PubMed Web of Science ®Google Scholar
• Lee J, Suh C, Park YH, . Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006;24:612–618.
   PubMed Web of Science ®Google Scholar
• Li YX, Liu QF, Fang H, . Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma. Clin Cancer Res 2009;15:2905–2912.
   PubMed Web of Science ®Google Scholar
• Lee J, Kim WS, Park YH, . Nasal-type NK/T cell lymphoma: clinical features and treatment outcome. Br J Cancer 2005;92: 1226–1230.
   PubMed Web of Science ®Google Scholar
• Mraz-Gernhard S, Natkunam Y, Hoppe RT, . Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol 2001;19:2179–2188.
   PubMed Web of Science ®Google Scholar
• Bekkenk MW, Jansen PM, Meijer CJ, . CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 2004;15: 1097–1108.
   PubMed Web of Science ®Google Scholar
• Choi YL, Park JH, Namkung JH, . Extranodal NK/T-cell lymphoma with cutaneous involvement: “nasal” vs. “nasal-type” subgroups: a retrospective study of 18 patients. Br J Dermatol 2009; 160:333–337.
   PubMed Web of Science ®Google Scholar
• Yu JB, Zuo Z, Tang Y, . Extranodal nasal-type natural killer/T-cell lymphoma of the skin: a clinicopathologic study of 16 cases in China. Hum Pathol 2009;40:807–816.
   PubMed Web of Science ®Google Scholar
• Massone C, Chott A, Metze D, . Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol 2004;28:719–735.
   PubMed Web of Science ®Google Scholar
• Willemze R, Jaffe ES, Burg G, . WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–3785.
   PubMed Web of Science ®Google Scholar
• Pincus LB, Zehnder JL, Neuhaus IM, . Presentation of extranodal natural killer T-cell lymphoma, nasal type, with poorly circumscribed erythematous patches. J Clin Oncol 2010;28:e94–e95.
   Google Scholar
• Kostal M, Marie Kostalova M, Belada D, . Cutaneous natural killer (NK)/T-cell lymphoma: nasal type with extensive facial destruction. Int J Dermatol 2009;48:1338–1342.
   PubMed Web of Science ®Google Scholar
• Tse E, Leung R, Khong PL, . Non-nasal natural killer cell lymphoma: not non-nasal after all. Ann Hematol 2009;88:185–187.
   PubMed Web of Science ®Google Scholar
• Stokkermans-Dubois J, Jouary T, Vergier B, . A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature. Dermatology 2006;213:345–349.
   PubMed Web of Science ®Google Scholar
• Sandner A, Helmbold P, Winkler M, . Cutaneous dissemination of nasal NK/T-cell lymphoma in a young girl. Clin Exp Dermatol 2008;33:615–618.
   PubMed Web of Science ®Google Scholar
• Child FJ, Mitchell TJ, Whittaker SJ, . Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the U.K. Br J Dermatol 2003;148: 507–515.
   PubMed Web of Science ®Google Scholar
• Gniadecki R, Rossen K, Ralfkier E, . CD56+ lymphoma with skin involvement: clinicopathologic features and classification. Arch Dermatol 2004;140:427–436.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Pinilla SM, Barrionuevo C, Garcia J, . EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from Peru in children and young adults. Am J Surg Pathol 2010;34:1773–1782.
   PubMed Web of Science ®Google Scholar
• Assaf C, Gellrich S, Whittaker S, . CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol 2007;60:981–989.
   PubMed Web of Science ®Google Scholar
• Chan JKC, Quintanilla-Martinez L, Ferry JA, . Extranodal NK/T-cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NL, ., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: International Agency for Research on Cancer Press; 2008. pp. 285–288.
   Google Scholar
• Wang ZY, Li YX, Wang WH, . Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents. Blood 2009;114:4771–4776.
   PubMed Web of Science ®Google Scholar
• Wang ZY, Li YX, Wang H, . Unfavorable prognosis of elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma. Ann Oncol 2011;22:390–396.
   PubMed Web of Science ®Google Scholar
• Li YX, Wang H, Jin J, . Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK/T-cell lymphoma. Int J Radiat Oncol Biol Phys 2011 Apr 4. [Epub ahead of print]
   Google Scholar
• Cheson BD, Horning SJ, Coiffier B, . Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999;17:1244–1253.
   PubMed Web of Science ®Google Scholar
• Cheung MM, Chan JK, Lau WH, . Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002; 54:182–190.
   PubMed Web of Science ®Google Scholar
• Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family. Nat Immunol 2010;11:197–206.
   PubMed Web of Science ®Google Scholar
• Pals ST, de Gorter DJJ, Spaargaren M. Lymphoma dissemination: the other face of lymphocyte homing. Blood 2007;110:3102–3111.
   PubMed Web of Science ®Google Scholar
• Cahu X, Bodet-Milin C, Brissot E, . 18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS group. Ann Oncol 2011;22:705–711.
   PubMed Web of Science ®Google Scholar
• Berti E, Recalcati S, Girgenti V, . Cutaneous extranodal NK/ T-cell lymphoma: a clinicopathologic study of 5 patients with array-based comparative genomic hybridization. Blood 2010;116:165–170.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Tobinai K, Oguchi M, . Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol 2009;27:5594–5600.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kim K, Kim BS, . Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: consortium for improving survival of lymphoma study. J Clin Oncol 2009;27:6027–6032.
   PubMed Web of Science ®Google Scholar
• Lee KW, Yun T, Kim DW, . First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma. Leuk Lymphoma 2006;47:1274–1282.
   PubMed Web of Science ®Google Scholar
• Yong WB, Zheng W, Zhu J, . L-Asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type. Ann Hematol 2009;88:647–652.
   PubMed Web of Science ®Google Scholar
• Li YX, Wang H, Feng XL, . Immunophenotypic characteristics and clinical relevance of CD56+ and CD56- extranodal nasal-type NK/T-cell lymphoma. Leuk Lymphoma 2011;52:417–424.
   PubMed Web of Science ®Google Scholar
• Ng SB, Selvarajan V, Huang G, . Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling. J Pathol 2011;223:496–510.
   PubMed Web of Science ®Google Scholar
• Wang WH, Li YX, Chen L, . Gene expression profile of nasal NK/T-cell lymphoma by cDNA microarray. Chin J Oncol 2006; 28:518–
   Google Scholar